Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling. (Q42026999)
Jump to navigation
Jump to search
scientific article published on 6 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling. |
scientific article published on 6 November 2015 |
Statements
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling (English)
Giovanni Riva
Adriana Mattiolo
Raffaella Bosco
Federica Gibellini
Chiara Frasson
Benedetta Accordi
Massimo Bonora
Gianluca Sgarbi
Alessandra Baracca
Daniela Milani
Anto De Pol
1 February 2016
1 reference
1 reference
1 reference
1 reference